Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1976-09-01
1983-01-25
Roberts, Elbert L.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
A61K 3156
Patent
active
043703216
ABSTRACT:
Oral treatment with megestrol acetate improves survival rate and reduces the recurrence rate in the adjuvant therapy of breast cancer following mastectomy.
REFERENCES:
Ansfield, et al, Cancer, 33 (1974), pp. 907-909.
Stoll, "British Medical Journal", (1967), No. 3, pp. 338-341.
Callantine Merritt R.
Greaney Martin O.
Carnahan Robert E.
Mead Johnson and Company
Roberts Elbert L.
LandOfFree
Progestational adjuvant therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Progestational adjuvant therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Progestational adjuvant therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1623658